Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| CREATIVE REALITIES, INC. | 6 352 | déclaré | 01 oct. 2019 | tx 2+6 352 |
| Apellis Pharmaceuticals, Inc. | 0 | déclaré | 14 mai 2026 | tx 171+872 750−1 744 829 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 14 mai 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 384 989 | — | |
| 14 mai 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 250 000 | — | |
| 14 mai 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 11 950 | — | |
| 14 mai 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 150 000 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 3 062 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 5 744 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 7 961 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 3 544 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 17 580 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 121 894 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 14 684 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 27 600 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 11 199 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 8 554 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 7 441 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 27 600 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 5 748 | — | deriv |
| 01 janv. 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 7 961 | 0.00 USD | |
| 01 janv. 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 14 684 | 0.00 USD | deriv |
| 01 janv. 2025 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 6 267 | 0.00 USD | |
| 01 janv. 2025 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 11 199 | 0.00 USD | deriv |
| 01 janv. 2024 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 3 341 | 0.00 USD | |
| 01 janv. 2024 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 5 748 | 59.86 USD | deriv |
| 17 nov. 2023 | EXERCISE | Apellis Pharmaceuticals, Inc. | 1 250 | 2.67 USD | |
| 17 nov. 2023 | SALE | Apellis Pharmaceuticals, Inc. | 1 250 | 47.74 USD |